ArticleCureus2024
First Case Report of Bilateral Avascular Necrosis in an Eosinophilic Esophagitis Patient on Swallowed Fluticasone.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Avascular necrosis (AVN) of the femoral head is a rare complication that can be associated with prolonged use of glucocorticoids. On reviewing the literature, this is the first case of bilateral AVN secondary to the long use of topical steroids in an eosinophilic esophagitis (EoE) patient. A 28-year-old man presented to our gastroenterology clinic for worsening fibrostenotic (EoE) despite being on swallowed fluticasone administered through an inhaler for seven years. The latter was stopped, and the patient was commenced on dupilumab. The patient was referred to orthopedics to manage his limping and groin pain. Bilateral hip replacements were performed when bilateral AVN was confirmed on MRI of both hips. The patient's EoE symptoms resolved after endoscopic dilation and an ongoing course of dupilumab. Furthermore, dupilumab showed an excellent control of the disease activity based on esophageal biopsies. To our knowledge, this is the first case report of such an entity. Our case highlights the need to promote awareness of such serious side effects of prolonged use of topical corticosteroids among healthcare providers, even if administered through a metered inhaler.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.